- AU$6.98m
- AU$8.23m
- AU$4.53m
Australia Stock Exchange release from ACRUX : Notification regarding unquoted securities - ACR
Australia Stock Exchange release from ACRUX : Application for quotation of securities - ACR
Australia Stock Exchange release from ACRUX : Securities Trading Policy
Australia Stock Exchange release from ACRUX : Whistleblower Policy
Australia Stock Exchange release from ACRUX : Appendix 3Y Brumley
Australia Stock Exchange release from ACRUX : Appendix 3Y Kotsanis
Australia Stock Exchange release from ACRUX : Notification of cessation of securities - ACR
Australia Stock Exchange release from ACRUX : Notification regarding unquoted securities - ACR
Australia Stock Exchange release from ACRUX : Amendment to Constitution
Australia Stock Exchange release from ACRUX : Appendix 3Y Brumley
Australia Stock Exchange release from ACRUX : Results of Annual General Meeting
Australia Stock Exchange release from ACRUX : Annual General Meeting Presentation and Addresses
Australia Stock Exchange release from ACRUX : R&D Tax Incentive Rebate received
Australia Stock Exchange release from ACRUX : Anti-Bribery, Corruption and Fraud Policy
Australia Stock Exchange release from ACRUX : JobKeeper disclosure
Australia Stock Exchange release from ACRUX : Annual Report to shareholders
Australia Stock Exchange release from ACRUX : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from ACRUX : Application for quotation of securities - ACR
Australia's Acrux falls on terminating licensing deal for anesthetic cream